239 related articles for article (PubMed ID: 12582458)
1. Obesity and metabolic syndrome: long-term benefits of central leptin gene therapy.
Kalra PS; Kalra SP
Drugs Today (Barc); 2002 Nov; 38(11):745-57. PubMed ID: 12582458
[TBL] [Abstract][Full Text] [Related]
2. Central leptin gene therapy blocks high-fat diet-induced weight gain, hyperleptinemia, and hyperinsulinemia: increase in serum ghrelin levels.
Dube MG; Beretta E; Dhillon H; Ueno N; Kalra PS; Kalra SP
Diabetes; 2002 Jun; 51(6):1729-36. PubMed ID: 12031959
[TBL] [Abstract][Full Text] [Related]
3. Leptin expression in hypothalamic PVN reverses dietary obesity and hyperinsulinemia but stimulates ghrelin.
Bagnasco M; Dube MG; Katz A; Kalra PS; Kalra SP
Obes Res; 2003 Dec; 11(12):1463-70. PubMed ID: 14694210
[TBL] [Abstract][Full Text] [Related]
4. Leptin modulates orexigenic effects of ghrelin and attenuates adiponectin and insulin levels and selectively the dark-phase feeding as revealed by central leptin gene therapy.
Ueno N; Dube MG; Inui A; Kalra PS; Kalra SP
Endocrinology; 2004 Sep; 145(9):4176-84. PubMed ID: 15155574
[TBL] [Abstract][Full Text] [Related]
5. Long-term suppression of weight gain, adiposity, and serum insulin by central leptin gene therapy in prepubertal rats: effects on serum ghrelin and appetite-regulating genes.
Beretta E; Dube MG; Kalra PS; Kalra SP
Pediatr Res; 2002 Aug; 52(2):189-98. PubMed ID: 12149495
[TBL] [Abstract][Full Text] [Related]
6. Central leptin gene therapy suppresses body weight gain, adiposity and serum insulin without affecting food consumption in normal rats: a long-term study.
Dhillon H; Kalra SP; Prima V; Zolotukhin S; Scarpace PJ; Moldawer LL; Muzyczka N; Kalra PS
Regul Pept; 2001 Jun; 99(2-3):69-77. PubMed ID: 11384767
[TBL] [Abstract][Full Text] [Related]
7. Caloric Restriction and Hypothalamic Leptin Gene Therapy Have Differential Effects on Energy Partitioning in Adult Female Rats.
Turner RT; Wong CP; Fosse KM; Branscum AJ; Iwaniec UT
Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34202651
[TBL] [Abstract][Full Text] [Related]
8. Dose-dependent effects of central leptin gene therapy on genes that regulate body weight and appetite in the hypothalamus.
Dhillon H; Kalra SP; Kalra PS
Mol Ther; 2001 Aug; 4(2):139-45. PubMed ID: 11482985
[TBL] [Abstract][Full Text] [Related]
9. Hypothalamic pro-opiomelanocortin gene delivery ameliorates obesity and glucose intolerance in aged rats.
Li G; Zhang Y; Wilsey JT; Scarpace PJ
Diabetologia; 2005 Nov; 48(11):2376-85. PubMed ID: 16205885
[TBL] [Abstract][Full Text] [Related]
10. Increased leptin expression in the dorsal vagal complex suppresses adiposity without affecting energy intake and metabolic hormones.
Boghossian S; Lecklin A; Dube MG; Kalra PS; Kalra SP
Obesity (Silver Spring); 2006 Jun; 14(6):1003-9. PubMed ID: 16861605
[TBL] [Abstract][Full Text] [Related]
11. Central leptin gene therapy corrects skeletal abnormalities in leptin-deficient ob/ob mice.
Iwaniec UT; Boghossian S; Lapke PD; Turner RT; Kalra SP
Peptides; 2007 May; 28(5):1012-9. PubMed ID: 17346852
[TBL] [Abstract][Full Text] [Related]
12. Hypothalamic leptin gene therapy prevents weight gain without long-term detrimental effects on bone in growing and skeletally mature female rats.
Iwaniec UT; Boghossian S; Trevisiol CH; Wronski TJ; Turner RT; Kalra SP
J Bone Miner Res; 2011 Jul; 26(7):1506-16. PubMed ID: 21328617
[TBL] [Abstract][Full Text] [Related]
13. Leptin gene transfer in the hypothalamus enhances longevity in adult monogenic mutant mice in the absence of circulating leptin.
Boghossian S; Ueno N; Dube MG; Kalra P; Kalra S
Neurobiol Aging; 2007 Oct; 28(10):1594-604. PubMed ID: 17011078
[TBL] [Abstract][Full Text] [Related]
14. Central leptin gene therapy blocks ovariectomy-induced adiposity.
Torto R; Boghossian S; Dube MG; Kalra PS; Kalra SP
Obesity (Silver Spring); 2006 Aug; 14(8):1312-9. PubMed ID: 16988073
[TBL] [Abstract][Full Text] [Related]
15. Short-term time-restricted feeding during the resting phase is sufficient to induce leptin resistance that contributes to development of obesity and metabolic disorders in mice.
Oishi K; Hashimoto C
Chronobiol Int; 2018 Oct; 35(11):1576-1594. PubMed ID: 30084652
[TBL] [Abstract][Full Text] [Related]
16. Gene-transfer technology: a preventive neurotherapy to curb obesity, ameliorate metabolic syndrome and extend life expectancy.
Kalra SP; Kalra PS
Trends Pharmacol Sci; 2005 Oct; 26(10):488-95. PubMed ID: 16125798
[TBL] [Abstract][Full Text] [Related]
17. Perigestational suppression of weight gain with central leptin gene therapy results in lower weight F1 generation.
Lecklin A; Dube MG; Torto RN; Kalra PS; Kalra SP
Peptides; 2005 Jul; 26(7):1176-87. PubMed ID: 15949636
[TBL] [Abstract][Full Text] [Related]
18. High-fat diet-induced ultradian leptin and insulin hypersecretion are absent in obesity-resistant rats.
Otukonyong EE; Dube MG; Torto R; Kalra PS; Kalra SP
Obes Res; 2005 Jun; 13(6):991-9. PubMed ID: 15976141
[TBL] [Abstract][Full Text] [Related]
19. Central leptin insufficiency syndrome: an interactive etiology for obesity, metabolic and neural diseases and for designing new therapeutic interventions.
Kalra SP
Peptides; 2008 Jan; 29(1):127-38. PubMed ID: 18053615
[TBL] [Abstract][Full Text] [Related]
20. Evidence for the existence of distinct central appetite, energy expenditure, and ghrelin stimulation pathways as revealed by hypothalamic site-specific leptin gene therapy.
Bagnasco M; Dube MG; Kalra PS; Kalra SP
Endocrinology; 2002 Nov; 143(11):4409-21. PubMed ID: 12399438
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
